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Abstract
Background: Memory consolidation, reconsolidation, and extinction have been shown to require new gene expression.
Poly ADP-ribosylation mediated by poly (ADP-ribose) polymerase-1 (PARP-1) is known to regulate transcription through
histone modification. Recent studies have suggested that PARP-1 positively regulates the formation of long-term
memory (LTM); however, the roles of PARP-1 in memory processes, especially processes after retrieval, remain unknown.
Results: Here, we show critical roles for PARP-1 in the consolidation, reconsolidation, and extinction of contextual fear
memory in mice. We examined the effects of pharmacological inhibition of PARP-1 activity in the hippocampus or
medial prefrontal cortex (mPFC) on these memory processes. Similarly with previous findings, a micro-infusion
of the PARP-1 inhibitor 3-aminobenzamide or PJ34 into the dorsal hippocampus, but not mPFC, impaired LTM
formation without affecting short-term memory (STM). Importantly, this pharmacological blockade of PARP-1 in
the dorsal hippocampus, but not mPFC, also disrupted post-reactivation LTM without affecting post-reactivation
STM. Conversely, micro-infusion of the PARP-1 inhibitors into the mPFC, but not dorsal hippocampus, blocked
long-term extinction. Additionally, systemic administration of the PARP-1 inhibitor Tiq-A blocked c-fos induction in
the hippocampus, which is observed when memory is consolidated or reconsolidated, and also blocked c-fos
induction in the mPFC, which is observed when memory is extinguished.
Conclusions: Our observations showed that PARP-1 activation is required for the consolidation, reconsolidation,
and extinction of contextual fear memory and suggested that PARP-1 contributes to the new gene expression
necessary for these memory processes.
Keywords: Poly (ADP-ribose) polymerase, Poly ADP-ribosylation, Hippocampus, Medial prefrontal cortex, Fear
conditioning, 3-aminobenzamide, PJ34, Tiq-A, Gene expression, c-fos
Background
Poly ADP-ribosylation of proteins is one of the revers-
ible post-translational modifications in eukaryotes and,
importantly, is involved in biological processes in the
nucleus such as transcriptional regulation, DNA repair,
and control of centrosomal division [1–3]. This poly
ADP-ribosylation is mainly catalyzed by the nuclear pro-
tein poly (ADP-ribose) polymerase-1 (PARP-1) [4–6].
Recent studies have shown that PARP-1 is expressed in
the central nervous system and is activated by neural
activity such as neuronal depolarization and stimulation
by nerve growth factor [7–9].
Short-term memory (STM) is labile. To generate a
stable long-term memory (LTM), a memory is stabi-
lized through a process known as memory consolida-
tion [10–12]. Previous studies have revealed that
when an LTM is retrieved, the memory returns to the la-
bile state again and is re-stabilized through the process of
reconsolidation, which is similar to that of consolidation
[13–16]. Conversely, memory extinction is induced by the
continuous or repeated retrieval of a fear memory, thereby
inhibiting fear responses [17–20]. The most common and
critical biochemical step of memory consolidation, recon-
solidation, and extinction is the requirement of new gene
expression [11, 13, 21–25]. Importantly, there is increasing
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evidence that post-translational modifications, such as
phosphorylation, acetylation, methylation, ubiquitination,
and SUMOylation, which regulate gene expression, play
an important role in the formation of LTM [26–35].
A contextual fear memory is an associative memory of
a context with conditioned fear arising from a stimulus
or event, such as an electrical footshock. Memory con-
solidation and reconsolidation of contextual fear have
been shown to depend on the hippocampus and require
gene expression in this brain region [23, 36–41]. In con-
trast, the medial prefrontal cortex (mPFC) is important
for long-term fear extinction, which also requires gene
expression in this brain region [24, 39, 42–44].
Recent pharmacological studies have shown that PARP-
1-mediated poly ADP-ribosylation of nuclear proteins in
Aplysia is necessary for gene expression-dependent long-
term facilitation and memory formation [45, 46]. Likewise,
there are reports that PARP-1 activation in rodents is
required for long-term potentiation and hippocampus-
dependent memory consolidation [47–50]. However, the
role of PARP-1 in gene expression-dependent memory
processes such as memory reconsolidation and extinction
remains unclear. In the present study, we clarified the role
of PARP-1 in the regulation of contextual fear memory.
To do this, we analyzed the effects of the pharmacological
inhibition of PARP-1 activity in the hippocampus and
mPFC on memory consolidation, reconsolidation, and
extinction of contextual fear.
Results
PARP-1 activity in the hippocampus is required for the
consolidation of contextual fear memory
Abundant studies have shown that the consolidation of
contextual fear memory depends on the hippocampus
[36–38]. Importantly, recent studies using pre-training
administration of PARP-1 inhibitors into the dorsal
hippocampus or lateral ventricle have shown that inhib-
ition of PARP-1 activity blocks memory consolidation
[47–49]. To understand further the roles of PARP-1 in
memory consolidation, we first asked whether hippo-
campal PARP-1 activity is required for the consolidation
of hippocampus-dependent contextual fear memory in
mice. To do this, the mice were trained with a single
footshock and tested 24 h later. They received a micro-
infusion of the PARP-1 inhibitor 3-aminobenzamide
(3AB; low- [9 μg/side] or high-dose [18 μg/side]) or ve-
hicle (VEH) into the dorsal hippocampus at 5 min before
(Fig. 1a) or immediately after (Fig. 1b) training. One-way
analysis of variance (ANOVA) revealed a significant effect
of drug when the mice received 3AB before, but not
immediately after, training (pre-training infusion:
F(2,33) = 3.419, p < 0.05; post-training infusion: F(1,25) =
0.176, p > 0.05; Fig. 1a and b). Post hoc Newman-Keuls
analysis revealed that mice treated with 3AB pre-training
froze significantly less than the VEH group in a dose-
dependent manner (VEH vs. low-dose: p > 0.05; VEH vs.
high-dose: p < 0.05; Fig. 1a). In contrast, mice treated with
3AB post-training showed comparable freezing with the
VEH group (p > 0.05; Fig. 1b). These observations indicated
that pre-, but not post-, training inhibition of hippocampal
PARP-1 impairs LTM formation of contextual fear.
We next examined the effect of a pre-training infusion
of 3AB on STM (2 h memory). We performed a similar
experiment as in Fig. 1a, except the mice were treated
with 3AB (18 μg/side) at 5 min before training and
tested at 2 h after training. One-way ANOVA revealed
no significant effect of drug (F(1,14) = 0.0003, p > 0.05;
Fig. 1c). This observation indicated that the inhibition of
hippocampal PARP-1 activity does not affect STM.
We examined the effects of another PARP-1 inhibitor
(PJ34) on LTM. We performed a similar experiment as in
Fig. 1a, except the mice received a micro-infusion of PJ34
at 5 min before training. One-way ANOVA revealed a sig-
nificant effect of drug (F(1,17) = 4.639, p < 0.05; Fig. 1d). The
PJ34 group froze significantly less than the VEH group (p <
0.05; Fig. 1d). These results were consistent with our obser-
vation in Fig. 1a and indicated that inhibition of hippocam-
pal PARP-1 blocks LTM formation of contextual fear.
As a control experiment, we examined the effects of
inhibiting PARP-1 activity in the mPFC on LTM formation
of contextual fear. We performed a similar experiment as
in Fig. 1a, except the mice received a micro-infusion of
3AB (18 μg) into the mPFC at 5 min before training.
One-way ANOVA revealed no significant effect of
drug (F(1,28) = 1.037, p > 0.05; Fig. 1e). This observation
suggested that PARP-1 activity in the mPFC is not re-
quired for the formation of contextual fear memory.
Taken together, similarly to previous findings [47–49],
we observed that inhibition of PARP-1 activity in the
hippocampus impairs LTM formation of contextual fear
without affecting STM. Our results suggested that hip-
pocampal PARP-1 activity is required for the consolida-
tion of contextual fear memory.
PARP-1 activity in the hippocampus is required for the
reconsolidation of contextual fear memory
Reconsolidation has been shown to involve molecular pro-
cesses similar to those of consolidation [13–16, 23, 39].
Furthermore, similarly to consolidation, the reconsoli-
dation of contextual memory depends on new gene ex-
pression in the hippocampus [23, 39–41]. Therefore, it is
possible that hippocampal PARP-1 activity is required for
the reconsolidation of contextual fear memory. To assess
this, we examined the effects of inhibiting hippocampal
PARP-1 on post-reactivation LTM (PR-LTM) of contextual
fear [25]. The mice were trained and 24 h later, they were
re-exposed to the training context for 3 min (re-exposure).
PR-LTM was tested at 24 h after re-exposure (test). The
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mice received a micro-infusion of 3AB (18 μg/side) or
VEH into the dorsal hippocampus at 5 min before (Fig. 2a)
or immediately after (Fig. 2b) re-exposure. During re-
exposure, comparable levels of freezing were observed be-
tween the VEH and 3AB groups (pre-re-exposure infusion:
F(1,17) = 0.112, p > 0.05; post-re-exposure infusion: F(1,17) =
0.429, p > 0.05; Fig. 2a and b). This observation indicated
that inhibiting PARP-1 activity does not affect the retrieval
of contextual fear memory. Two-way ANOVA revealed
significant drug (VEH vs. 3AB) × time (re-exposure vs. test)
interactions (pre-re-exposure infusion: drug, F(1,17) = 5.140,
p > 0.05 ; time, F(1,17) = 1.285, p > 0.05; interaction, F(1,17) =
8.333, p < 0.05; post-re-exposure infusion: drug, F(1,17) =
5.938, p < 0.05; time, F(1,17) = 3.633, p > 0.05; interaction,
F(1,17) = 7.505, p < 0.05; Fig. 2a and b). Post hoc Newman-
Keuls analysis revealed that the 3AB groups froze
significantly less than the VEH groups during the test
(pre-re-exposure infusion: p < 0.05; post-re-exposure
infusion: p < 0.05; Fig. 2a and b). These results indicated
that in contrast to the results of the consolidation experi-
ments (Fig. 1a and b), post- as well as pre-re-exposure in-
hibition of PARP-1 activity in the hippocampus disrupted
PR-LTM, suggesting that the reconsolidation of contextual
fear memory shows a similar requirement for PARP-1
activation as consolidation, but has different time win-
dows for this activation.
We next examined the effect of 3AB infusion on
post-reactivation STM (PR-STM). The mice received a
micro-infusion of 3AB immediately after re-exposure
and 2 h later, they were tested. Two-way ANOVA re-
vealed no significant effect of drug and time or a
drug × time interaction (drug, F(1,16) = 0.001, p > 0.05;
time, F(1,16) = 0.127, p > 0.05; interaction, F(1,16) = 0.054,
p > 0.05; Fig. 2c). This observation indicated that inhi-
biting PARP-1 activity in the hippocampus does not
affect PR-STM.
As a control experiment, we asked whether the disrup-
tion of contextual fear memory by 3AB depends on
memory retrieval. We performed a similar experiment
as in Fig. 2b, except the mice were not re-exposed to the
context. One-way ANOVA revealed no significant
effect of drug (F(1,17) = 0.237, p > 0.05; Fig. 2d). This
result indicated that inhibiting PARP-1 activity failed
to disrupt contextual fear memory when the memory
was not retrieved. Taken together, these results sug-
gested that inhibiting hippocampal PARP-1 activity
impairs the reconsolidation of contextual fear memory
following retrieval.
Fig. 1 Inhibition of PARP-1 activity in the hippocampus blocks the consolidation of contextual fear memory. a Effects of a micro-infusion of
low- or high-dose of 3AB into the dorsal hippocampus at 5 min before training on LTM (VEH, n = 12; 3AB-9 μg, n = 12; 3AB-18 μg, n = 12).
b Effects of a micro-infusion of 3AB into the dorsal hippocampus immediately after training on LTM (VEH, n = 13; 3AB, n = 14). c Effects of a
micro-infusion of 3AB into the dorsal hippocampus at 5 min before training on STM (VEH, n = 8; 3AB, n = 8). d Effects of a micro-infusion of PJ34
into the dorsal hippocampus at 5 min before training on LTM (VEH, n = 9; PJ34, n = 10). e Effects of a micro-infusion of 3AB into the mPFC at
5 min before training on LTM (VEH, n =15; 3AB, n = 15). *p < 0.05, compared with the VEH group at the test. Error bars indicate SEM
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We observed similar results using a micro-infusion of
PJ34. We performed a similar experiment as in Fig. 2b,
except the mice received a micro-infusion of PJ34 imme-
diately after re-exposure. Two-way ANOVA revealed a
significant drug × time interaction (drug, F(1,12) = 2.773,
p > 0.05; time, F(1,12) = 6.410, p < 0.05; interaction,
F(1,12) = 4.929, p < 0.05; Fig. 2e). The PJ34 group froze
significantly less than the VEH group during the test
(p < 0.05; Fig. 2e). These results support our finding
in Fig. 2b and indicated that inhibiting hippocampal
PARP-1 activity blocks memory reconsolidation.
Finally, we examined the effects of inhibiting PARP-1
activity in the mPFC on the reconsolidation of contextual
fear memory. We performed a similar experiment as in
Fig. 2b, except the mice received a micro-infusion of 3AB
(18 μg) into the mPFC immediately after re-exposure.
Fig. 2 Inhibition of PARP-1 activity in the hippocampus blocks the reconsolidation of contextual fear memory. a, b Effects of a micro-infusion of
3AB into the dorsal hippocampus at 5 min before (a) or immediately after (b) the 3 min re-exposure on PR-LTM (pre-re-exposure infusion: VEH,
n = 9; 3AB, n = 10; post-re-exposure infusion: VEH, n = 9; 3AB, n = 10). c Effects of a micro-infusion of 3AB into the dorsal hippocampus immediately
after the 3 min re-exposure on PR-STM (VEH, n = 10; 3AB, n = 8). d Effects of a micro-infusion of 3AB into the dorsal hippocampus at 24 h after
training without re-exposure on LTM (VEH, n = 9; 3AB, n = 10). e Effects of a micro-infusion of PJ34 into the dorsal hippocampus immediately
after the 3 min re-exposure on PR-LTM (VEH, n = 7; PJ34, n = 7). f Effects of a micro-infusion of 3AB into the mPFC immediately after the 3 min
re-exposure on PR-LTM (VEH, n = 9; 3AB, n = 10). *p < 0.05, compared with the VEH group at the test. Error bars indicate SEM
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Two-way ANOVA revealed no significant effects of drug
and time or a drug × time interaction (drug, F(1,17) =
0.0003, p > 0.05; time, F(1,17) = 0.170, p > 0.05; interaction,
F(1,17) = 0.202, p > 0.05; Fig. 2f). This observation indicated
that inhibiting PARP-1 activity in the mPFC is not re-
quired for the reconsolidation of contextual fear memory.
Taken together, these observations that inhibiting
PARP-1 activity in the hippocampus, but not mPFC,
disrupts PR-LTM without affecting PR-STM, suggested
that hippocampal PARP-1 activity is required for the
reconsolidation of contextual fear memory.
PARP-1 activity in the mPFC is required for the long-term
extinction of contextual fear memory
Previous studies have shown that not only consolidation
and reconsolidation but also the long-term extinction of
fear memory depend on gene expression, suggesting that
long-term extinction shows similar molecular signa-
tures as consolidation and reconsolidation [24, 25, 39].
However, a previous study showed that the long-term ex-
tinction of contextual fear memory depends on the mPFC,
but not hippocampus [39]. Therefore, we examined the
effects of inhibiting PARP-1 activity in the mPFC on the
extinction of contextual fear memory [39]. The mice were
trained, and 24 h later, they were re-exposed to the con-
text for 30 min. Extinction memory was tested at 24 h
after re-exposure. The mice received a micro-infusion of
3AB (18 μg) or VEH into the mPFC at 5 min before
(Fig. 3a) or immediately after (Fig. 3b) re-exposure. The
VEH and 3AB groups showed that freezing levels de-
creased over time with re-exposure (pre-re-exposure infu-
sion: F(5,95) = 68.119, p < 0.05; post-re-exposure infusion:
F(5,60) = 58.017, p < 0.05; Fig. 3a and b), and that overall
freezing levels did not differ during re-exposure (pre-
re-exposure infusion: F(1,19) = 0.241, p > 0.05; post-re-
exposure infusion: F(1,12) = 0.769, p > 0.05; Fig. 3a and b).
These results indicated that both groups displayed
comparable within-session extinction, suggesting that
inhibiting PARP-1 activity in the mPFC does not affect
within-session extinction. Two-way ANOVA revealed a
significant drug × time (last 5 min in re-exposure vs. test)
interaction (pre-re-exposure infusion: drug, F(1,19) = 3.083,
Fig. 3 Inhibition of PARP-1 activity in the mPFC blocks the long-term extinction of contextual fear memory. a, b Effects of a micro-infusion of 3AB
into the mPFC at 5 min before (a) or immediately after (b) the 30 min re-exposure on long-term extinction (pre-re-exposure infusion: VEH, n = 10;
3AB, n = 11; post-re-exposure infusion: VEH, n = 7; 3AB, n = 7). c Effects of a micro-infusion of PJ34 into the mPFC immediately after the 30 min
re-exposure on long-term extinction (VEH, n = 8; PJ34, n = 7). d Effects of a micro-infusion of 3AB into the dorsal hippocampus immediately after
the 30 min re-exposure on long-term extinction (VEH, n = 9; 3AB, n = 9). *p < 0.05, compared with the VEH group at the test. Error bars
indicate SEM
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p > 0.05; time, F(1,19) = 25.892, p < 0.05; interaction,
F(1,19) = 5.291, p < 0.05; post-re-exposure infusion:
drug, F(1,12) = 16.056, p < 0.05; time, F(1,12) = 27.813, p <
0.05; interaction, F(1,12) = 7.458, p < 0.05; Fig. 3a and b).
Post hoc Newman-Keuls analysis revealed that the 3AB
groups froze significantly more than the VEH groups dur-
ing the test (pre-re-exposure infusion: p < 0.05; post-re-
exposure infusion: p < 0.05; Fig. 3a and b). Importantly,
measurements at 24 h after this 30 min re-exposure con-
firmed that the extinction of conditioned freezing per-
sisted in the VEH groups (first 5 min in re-exposure vs.
test; pre-re-exposure infusion: t(9) = 4.276, p < 0.05; post-
re-exposure infusion: t(6) = 6.267, p < 0.05; Fig. 3a and b),
indicating that the VEH groups showed long-term extinc-
tion. These results indicated that inhibiting PARP-1 activ-
ity in the mPFC blocks long-term extinction, suggesting
that PARP-1 in the mPFC is required for this process.
We observed similar results using a micro-infusion of
PJ34. The mice were treated similarly as above, except
they received a micro-infusion of PJ34 immediately after
re-exposure. The VEH and PJ34 groups showed compar-
able within-session extinction (decrease over time,
F(5,65) = 42.074, p < 0.05; overall freezing, F(1,13) = 0.433,
p > 0.05; Fig. 3c). Two-way ANOVA revealed a significant
drug × time interaction (drug, F(1,13) = 1.462, p > 0.05; time,
F(1,13) = 14.789, p < 0.05; interaction, F(1,13) = 7.510, p <
0.05; Fig. 3c). The PJ34 group froze significantly more than
the VEH group during the test (p < 0.05; Fig. 3c). These
results indicated that inhibiting PARP-1 activity in the
mPFC with PJ34 blocks long-term extinction.
Finally, we examined the effects of inhibiting hippo-
campal PARP-1 activity on long-term extinction. We
performed a similar experiment as in Fig. 3b, except the
mice received a micro-infusion of 3AB (18 μg/side) into
the dorsal hippocampus. The VEH and 3AB groups
showed comparable within-session extinction (decrease
over time, F(5,80) = 21.435, p < 0.05; overall freezing;
F(1,16) = 0.004, p > 0.05; Fig. 3d). In contrast to the result
of the mPFC, two-way ANOVA revealed no significant
effects of drug and time or a drug × time interaction (drug,
F(1,16) = 0.243, p > 0.05; time, F(1,16) = 4.085, p > 0.05; inter-
action, F(1,16) = 0.052, p > 0.05; Fig. 3d). These results
indicated that PARP-1 activity in the hippocampus is not
required for long-term extinction.
Taken together, our observations suggested that PARP-1
activity in the mPFC, but not hippocampus, is required
for the long-term extinction of contextual fear memory.
PARP-1 activity is required for gene expression during
the consolidation, reconsolidation, and extinction of
contextual fear memory
The consolidation, reconsolidation, and extinction of con-
textual fear memory are known to depend on new gene
expression [23, 25, 36, 39]. It is possible that PARP-1
contributes to these memory processes through the activa-
tion of gene expression. To assess this possibility, we
examined the effects of PARP-1 inactivation on the
expression of the immediate-early gene c-fos, which is
induced in these memory processes [24, 39, 51–53].
Consolidation
We first examined the effects of a systemic injection of the
brain-permeable PARP-1 inhibitor Tiq-A on the consolida-
tion of contextual fear memory at the behavioral level. We
performed similar experiments as in Fig. 1a and c, except
the mice were systemically injected with Tiq-A at 30 min
before training. One-way ANOVA revealed a significant
effect of drug when the mice were tested at 24 h, but not
at 2 h, after training (24 h memory: F(1,14) = 6.424, p < 0.05;
2 h memory: F(1,18) = 0.036, p > 0.05; Fig. 4a and b). The
Tiq-A group froze significantly less than the VEH group at
24 h after training (p < 0.05; Fig. 4a). Similarly to Fig. 1,
these observations indicated that PARP-1 inhibition by
Tiq-A blocks the consolidation of contextual fear memory.
We measured the number of c-fos-positive cells in the
hippocampus and mPFC at 90 min after training using
immunohistochemistry (IHC). Two groups were trained
with a footshock (shock groups), and the remaining two
groups did not receive a footshock (no-shock groups).
At 30 min before training, these groups were systemic-
ally injected with Tiq-A or VEH (shock/Tiq-A, shock/
VEH, no-shock/Tiq-A, and no-shock/VEH groups)
(Fig. 4c). Two-way ANOVA revealed a significant condi-
tioning × drug interaction only in the CA1 region of the
hippocampus (conditioning, F(1,27) = 13.273, p < 0.05;
drug, F(1,27) = 5.532, p < 0.05; interaction, F(1,27) = 7.742,
p < 0.05; Fig. 4d and e), but not in the dentate gyrus
(DG) region of the hippocampus or prelimbic (PL) and
infralimbic (IL) regions of the mPFC (DG: conditioning,
F(1,27) = 0.237, p > 0.05; drug, F(1,27) = 0.000, p > 0.05;
interaction, F(1,27) = 1.201, p > 0.05; PL: conditioning,
F(1,27) = 0.411, p > 0.05; drug, F(1,27) = 0.117, p > 0.05;
interaction, F(1,27) = 4.180, p > 0.05; IL: conditioning,
F(1,27) = 1.713, p > 0.05; drug, F(1,27) = 0.491, p > 0.05;
interaction, F(1,27) = 0.039, p > 0.05; Fig. 4d and e). The
shock/VEH group showed significantly more c-fos-
positive cells in the hippocampal CA1 area compared
with the other groups (p < 0.05; Fig. 4d and e). These re-
sults indicated that PARP-1 inactivation by Tiq-A blocks
c-fos induction in the hippocampus when memory is
consolidated.
Reconsolidation
To examine whether the systemic injection of Tiq-A
blocks the reconsolidation of contextual fear memory, we
performed a similar experiment as in Fig. 2a, except
the mice were systemically injected with Tiq-A at
30 min before the 3 min re-exposure. During re-
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exposure, comparable levels of freezing were observed
between the VEH and Tiq-A groups (F(1,18) = 0.035,
p > 0.05; Fig. 5a). Two-way ANOVA revealed a signifi-
cant drug × time (re-exposure vs. test) interaction (drug,
F(1,18) = 3.082, p > 0.05 ; time, F(1,18) = 8.143, p < 0.05; inter-
action, F(1,18) = 7.559, p < 0.05; Fig. 5a). The Tiq-A group
froze significantly less than the VEH group during the test
(p < 0.05; Fig. 5a). Similarly to Fig. 2, these observations
indicated that PARP-1 inactivation by Tiq-A blocks the
reconsolidation of contextual fear memory.
Similarly to Fig. 4, we performed IHC at 90 min after
the 3 min re-exposure using four groups (shock/Tiq-A,
shock/VEH, no-shock/Tiq-A, and no-shock/VEH groups).
At 30 min before re-exposure, these groups were system-
ically injected with Tiq-A or VEH (Fig. 5b). Two-way
ANOVA revealed a significant conditioning × drug inter-
action in the hippocampal CA1 region (conditioning,
F(1,52) = 3.215, p > 0.05; drug, F(1,52) = 5.169, p < 0.05; inter-
action, F(1,52) = 4.420, p < 0.05; 5c and d), but not in the
DG, PL, and IL regions (DG: conditioning, F(1,52) = 0.052,
p > 0.05; drug, F(1,52) = 0.106, p > 0.05; interaction, F(1,52) =
2.130, p > 0.05; PL: conditioning, F(1,52) = 0.490, p > 0.05;
drug, F(1,52) = 0.074, p > 0.05; interaction, F(1,52) = 0.363,
p > 0.05; IL: conditioning, F(1,52) = 0.024, p > 0.05; drug,
Fig. 4 PARP-1 inactivation blocks c-fos induction in the hippocampal CA1 region when memory is consolidated. a, b Effects of a systemic injection of
Tiq-A at 30 min before training on LTM (a) and STM (b) (LTM: VEH, n = 8; Tiq-A, n = 8; STM: VEH, n = 10; Tiq-A, n = 10). *p < 0.05, compared with the
VEH group at the test. c Experimental design for IHC. d Representative immunohistochemical staining of c-fos-positive cells in the CA1, DG, PL, and IL
regions from the indicated mice. Scale bar, 50 μm. e Expression of c-fos in the CA1, DG, PL, and IL regions (n = 7–8 for each group). The expression of
c-fos in each group is expressed as the ratio of the no-shock/VEH group to the other groups. *p < 0.05, compared with the other groups. Error bars
indicate SEM
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F(1,52) = 0.208, p > 0.05; interaction, F(1,52) = 0.649, p > 0.05;
Fig. 5c and d). The shock/VEH group showed significantly
more c-fos-positive cells in the CA1 area compared with
the other groups (p < 0.05; Fig. 5c and d). These results
indicated that PARP-1 inactivation blocks c-fos induction
in the hippocampus when memory is reconsolidated.
Extinction
To examine whether the systemic injection of Tiq-A
blocks long-term extinction, we performed a similar ex-
periment as in Fig. 3a, except the mice were systemically
injected with Tiq-A at 30 min before the 30 min re-
exposure. The VEH and Tiq-A groups showed compar-
able within-session extinction (decrease over time,
F(5,150) = 31.728, p < 0.05; overall freezing, F(1,30) =
0.691, p > 0.05; Fig. 6a). Two-way ANOVA revealed a
significant drug × time (last 5 min in re-exposure vs.
test) interaction (drug, F(1,30) = 3.187, p > 0.05 ; time,
F(1,30) = 2.516, p > 0.05; interaction, F(1,30) = 6.014, p < 0.05;
Fig. 6a). The Tiq-A group froze significantly more
than the VEH group during the test (p < 0.05; Fig. 6a).
Similarly to Fig. 3, these observations indicated that
PARP-1 inactivation by Tiq-A blocks long-term fear
extinction.
Fig. 5 PARP-1 inactivation blocks c-fos induction in the hippocampal CA1 region when memory is reconsolidated. a Effects of the systemic injection
of Tiq-A at 30 min before the 3 min re-exposure on PR-LTM (VEH, n = 10; Tiq-A, n = 10). *p < 0.05, compared with the VEH group at the
test. b Experimental design for IHC. c Representative immunohistochemical staining of c-fos-positive cells in the CA1, DG, PL, and IL regions from the
indicated mice. Scale bar, 50 μm. d Expression of c-fos in the CA1, DG, PL, and IL regions (n = 11–17 for each group). The expression of c-fos in each
group is expressed as the ratio of the no-shock/VEH group to the other groups. *p < 0.05, compared with the other groups. Error bars indicate SEM
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Similarly to Fig. 5, we performed IHC at 90 min after
the 30 min re-exposure using four groups. At 30 min be-
fore re-exposure, these groups were systemically injected
with Tiq-A or VEH (Fig. 6b). Two-way ANOVA revealed
a significant conditioning × drug interaction in the PL
and IL regions of the mPFC (PL: conditioning, F(1,38) =
0.252, p > 0.05; drug, F(1,38) = 12.902, p < 0.05; interaction,
F(1,38) = 8.967, p < 0.05; IL: conditioning, F(1,38) = 2.683, p >
0.05; drug, F(1,38) = 4.277, p < 0.05; interaction, F(1,38) =
5.511, p < 0.05; 6c and d), but not in the hippocampal
CA1 and DG regions (CA1: conditioning, F(1,38) = 0.833,
p > 0.05; drug, F(1,38) = 3.476, p > 0.05; interaction, F(1,38) =
0.303, p > 0.05; DG: conditioning, F(1,38) = 0.057, p > 0.05;
drug, F(1,38) = 0.001, p > 0.05; interaction, F(1,38) = 0.341,
p > 0.05; Fig. 6c and d). The shock/VEH group showed
significantly more c-fos-positive cells in the PL and IL
areas compared with the other groups (p < 0.05; Fig. 6c
and d). These results indicated that PARP-1 inactivation
blocks c-fos induction in the mPFC when memory is
extinguished.
Collectively, our results suggested that PARP-1 activity
contributes to the consolidation, reconsolidation, and
Fig. 6 PARP-1 inactivation blocks c-fos induction in the mPFC when memory is extinguished. a Effects of the systemic injection of Tiq-A at 30 min
before the 30 min re-exposure on long-term extinction (VEH, n = 17; Tiq-A, n = 15). *p < 0.05, compared with the VEH group at the test. b Experimental
design for IHC. c Representative immunohistochemical staining of c-fos-positive cells in the CA1, DG, PL, and IL regions from the indicated mice. Scale
bar, 50 μm. d Expression of c-fos in the CA1, DG, PL, and IL regions (n = 8–13 for each group). The expression of c-fos in each group is expressed as
the ratio of the no-shock/VEH group to the other groups. *p < 0.05, compared with the other groups. Error bars indicate SEM
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extinction of contextual fear memory through the activa-
tion of new gene expression.
Inhibition of PARP-1 activity does not affect locomotor
activity or anxiety-related behavior
To test the possibility that the impairment of memory
processes observed by inhibiting PARP-1 activity is
attributed to abnormal locomotor and/or emotional
behavior, we investigated the effects of a micro-infusion
of 3AB into the dorsal hippocampus or mPFC on loco-
motor activity and anxiety-related behavior in an open
field test. The mice received a micro-infusion of 3AB or
VEH into the dorsal hippocampus (18 μg/side; Fig. 7a)
or mPFC (18 μg; Fig. 7b), respectively, at 5 min before
the test. One-way ANOVA revealed no significant effects
of drug on total path or percentage of time spent in the
center of the field (hippocampus: total distance, F(1,13) =
0.782, p > 0.05; % center, F(1,13) = 0.561, p > 0.05; mPFC:
total distance, F(1,16) = 0.479, p > 0.05; % center, F(1,16) =
0.066, p > 0.05; Fig. 7a and b), indicating that a micro-in-
fusion of 3AB into the dorsal hippocampus or mPFC does
not affect locomotor activity or anxiety-like behavior. We
next examined the effects of a systemic injection of Tiq-
A. Similarly to the results of 3AB micro-infusion,
Tiq-A treatment did not affect spontaneous behavior
in the open field test (total distance, F(1,38) = 0.731,
p > 0.05; % center, F(1,38) = 0.616, p > 0.05; Fig. 7c).
These results suggest that the impairment of memory
processes observed by PARP-1 inhibition is not due
to nonspecific effects of the drugs on locomotor ac-
tivity and/or emotional behavior.
Discussion
Recent studies have shown that PARP-1 activity and
PARP-1-mediated poly ADP-ribosylation are required
for LTM formation of fear memory [47, 49]. In the
present study, we examined the roles of PARP-1 in
the hippocampus and mPFC in the consolidation, re-
consolidation, and extinction of contextual fear mem-
ory. Inhibiting dorsal hippocampal PARP-1 activity by
a local infusion of the PARP-1 inhibitor 3AB or PJ34
blocked LTM formation without affecting STM. Simi-
larly, inhibition of PARP-1 before or after memory re-
trieval disrupted PR-LTM without affecting PR-STM.
Conversely, inhibition of PARP-1 in the mPFC, but not
hippocampus, blocked long-term extinction without af-
fecting within-session extinction. Therefore, these obser-
vations showed that PARP-1 activity in the hippocampus
is required for the consolidation and reconsolidation of
contextual fear memory, whereas PARP-1 activity in the
mPFC is required for its long-term extinction.
The hippocampus is known to play an essential role in
the consolidation of contextual fear memory [36–38]. Pre-
vious studies have shown that PARP-1-mediated poly
ADP-ribosylation occurs in the hippocampus after training
in an object recognition task [47, 48]. Likewise, we also
found that inhibiting hippocampal PARP-1 activity blocked
the consolidation of contextual fear memory. Therefore,
the induction of poly ADP-ribosylation following PARP-1
Fig. 7 Inhibition of PARP-1 activity does not affect locomotor activity or anxiety-related behavior. a, b Effects of a micro-infusion of 3AB into the
dorsal hippocampus (a) or mPFC (b) at 5 min before the open field test (dorsal hippocampus: VEH, n = 7; 3AB, n = 8; mPFC: VEH, n = 9; 3AB, n = 9).
c Effects of a systemic injection of Tiq-A at 30 min before the open field test (VEH, n = 20; Tiq-A, n = 20). Total path length for 5 min (left panel).
Percentage of time spent in the center for 5 min (right panel). Error bars indicate SEM
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activation in the hippocampus is suggested to play a critical
role in hippocampus-dependent memory consolidation.
Previous studies have shown that histone modifica-
tions, including phosphorylation, acetylation, and methy-
lation, in the hippocampus and mPFC are necessary for
the consolidation, reconsolidation, and extinction of fear
memory [32, 34, 54, 55]. Indeed, these histone modi-
fications are required for the transcriptional activation of
brain-derived neurotrophic factor (BDNF) and Zif268,
both of which contribute to the progress of gene
expression-dependent memory processes [34, 54, 55].
Interestingly, histones, whose modification remodels chro-
matin structure, have been shown to be a major target of
poly ADP-ribosylation mediated by PARP-1, resulting in
transcriptional regulation [1, 3–6, 56]. Most importantly,
previous studies have suggested that chromatin remodel-
ing through poly ADP-ribosylation is necessary for mem-
ory consolidation [48]. In this study, we showed that
inhibiting PARP-1 activity not only disrupted the consoli-
dation, reconsolidation, and extinction of contextual fear
memory but also blocked the induction of c-fos expres-
sion observed in these memory processes. Collectively, it
is likely that the PARP-1-mediated poly ADP-ribosylation
of histones and subsequent activation of gene expression
are required for the consolidation, reconsolidation, and
extinction of contextual fear memory. Therefore, it is
important to identify critical target proteins that are poly
ADP-ribosylated by PARP-1 and required for gene
expression-dependent memory processes.
A previous study showed that the systemic injection of
3AB did not affect locomotor activity in an open field
test [57]. Likewise, the present study also indicated that
the systemic injection of Tiq-A and local infusion of 3AB
into the dorsal hippocampus or mPFC did not affect loco-
motor activity or anxiety-related behavior. Therefore,
these observations suggested that the memory impairment
observed following the infusion of PARP-1 inhibitors is
not due to abnormalities of spontaneous locomotor activ-
ity or anxiety-related behavior, but rather appears to be
due to the inhibition of memory processes.
LTM formation in Aplysia is inhibited by 3AB adminis-
tration prior to operant conditioning, but not immediately
after training [45]. Likewise, the present study showed that
LTM formation of contextual fear was disrupted by
the infusion of PARP-1 inhibitors into the dorsal
hippocampus at 5 min before, but not immediately
after, training. Our previous study indicated that
inhibition of gene expression by the administration of
the protein synthesis inhibitor anisomycin immedi-
ately after training disrupted LTM of contextual fear
[41]. These findings suggested that PARP-1 activation
is likely to be necessary in the early stage of memory
consolidation processes such as during or immediately
after training.
The molecular mechanisms of both memory consoli-
dation and reconsolidation seem to be similar, but also
show differences from each other [58, 59]. For example,
hippocampal BDNF is required for the consolidation of
contextual fear memory, while hippocampal Zif268 is re-
quired for the reconsolidation of this memory [37, 60, 61].
Unlike in the case of the infusion of PARP-1 inhibitors
against the consolidation of contextual fear memory, the
present study showed that both the pre- and post-re-
exposure local infusion of PARP-1 inhibitors into the
dorsal hippocampus blocked memory reconsolidation.
Therefore, this result suggests that the consolidation and
reconsolidation mechanisms are similar, but they work
differently; that is, PARP-1 activation functions in
different time windows during memory consolidation
and reconsolidation.
Transcriptional activation by the transcription factor
cAMP responsive element binding protein (CREB) is
known to be necessary for the consolidation, reconsolida-
tion, and long-term extinction of contextual fear memory
[10, 14, 36, 39, 62]. A recent study showed that PARP-1 ac-
tivity is necessary to induce hippocampal expression of the
CREB-target gene c-fos after training in an object recogni-
tion task [48]. Another study showed that PARP-1 inhib-
ition in the hippocampus leads to decreases in cAMP level,
PKA activity, PKAcα expression, and CREB phosphoryl-
ation. Thus, these findings suggest that PARP-1 positively
regulates the cAMP-PKA-CREB pathway [49]. In this
study, we found that PARP-1 activation is required for
memory consolidation, reconsolidation, and long-term ex-
tinction; furthermore, PARP-1 activity is required for c-fos
induction when memory is consolidated, reconsolidated,
and extinguished. Taken together, these findings raise the
possibility that PARP-1 facilitates memory processes
through the activation of CREB-mediated gene expression.
Conclusions
In the current study, we showed that PARP-1 activity in
the hippocampus is necessary for both the consolidation
and reconsolidation of contextual fear memory; moreover,
this activity in the mPFC is necessary for long-term ex-
tinction. Taken together, our study suggests that PARP-1-
mediated poly ADP-ribosylation has a crucial role not
only in memory formation of contextual fear conditioning
but also in regulation after memory retrieval.
Methods
Mice
All experiments were conducted according to the Guide
for the Care and Use of Laboratory Animals, Japan
Neuroscience Society and Tokyo University of Agriculture.
All animal experiments performed in this study were
approved by the Animal Care and Use Committee of
Tokyo University of Agriculture. Male C57BL/6N mice
Inaba et al. Molecular Brain  (2015) 8:63 Page 11 of 15
were obtained from Charles River (Yokohama, Japan).
The mice were housed in cages of 5 or 6, maintained on
a 12 h light/dark cycle, and allowed ad libitum access to
food and water. The mice were at least 8 weeks of age at
the start of the experiments, and all behavioral proce-
dures were conducted during the light phase of the
cycle. All experiments were conducted blind to the treat-
ment condition of the mice.
Surgery and micro-infusion
Surgery was performed as described previously [39–41,
63–67]. Under Nembutal anesthesia and using standard
stereotaxic procedures, a stainless steel guide cannula
(22 gauge) was implanted into the dorsal hippocampus
(−1.9 mm, ± 1.8 mm, −1.9 mm) or mPFC (2.0 mm, ±
0 mm, −1.6 mm) [68]. The mice were allowed to recover
for at least 1 week after surgery. Infusions into the dor-
sal hippocampus (0.5 μL/side) or mPFC (0.5 μL) were
made at a rate of 0.25 μL/min. The injection cannula
was left in place for 2 min after infusion. Only mice
with a cannulation tip within the boundaries of the
dorsal hippocampus or mPFC were included in the data
analysis. Cannulation tip placements are shown in
Fig. 8.
Drugs
The PARP-1 inhibitors 3AB (18 or 36 μg/μL; Sigma, MO,
USA), PJ34 (0.2 mM; Enzo Life Sciences, NY, USA), and
Tiq-A (0.5 mg/kg; Sigma) were dissolved in dimethyl sulf-
oxide (DMSO). Local administration of PJ34 (0.2 mM)
into the lateral ventricle blocked PARP-1 activation and
the consolidation of object recognition and inhibitory
avoidance memories [47]. Systemic administration of Tiq-
A (0.5 mg/kg) blocked PARP-1 activation and the consoli-
dation of object recognition memory [48]. 3AB and PJ34
were diluted in artificial cerebrospinal fluid and saline, re-
spectively, to a final DMSO concentration of 10 %. Tiq-A
was diluted in saline to a final DMSO concentration of
1 %.
Contextual fear conditioning task
The mice were handled for 5 consecutive days prior to
the commencement of contextual fear conditioning. The
mice were trained and tested in conditioning chambers
(17.5 × 17.5 × 15 cm) that had a stainless steel grid floor
through which a footshock could be delivered [25, 39,
41, 63, 69]. Training consisted of placing the mice in the
chamber and delivering an unsignaled footshock (2 s
duration, 0.4 mA) at 148 s later, and then the mice were
returned to their homecage at 30 s after the footshock
(training).
For the experiments to examine the effects of drug
treatment on memory consolidation, the mice received a
micro-infusion of 3AB, PJ34, or VEH into the dorsal
hippocampus or mPFC at 5 min before or immediately
after training (see Fig. 1). At 2 or 24 h after training, the
mice were placed back in the training context for 5 min
(test). For the experiments to examine the effects of drug
treatment on memory reconsolidation or extinction, the
mice were trained and placed back in the training con-
text at 24 h later for 0, 3, or 30 min (re-exposure). The
mice received a micro-infusion of 3AB, PJ34, or VEH
into the dorsal hippocampus or mPFC at 5 min before
or immediately after re-exposure (see Figs. 2 and 3). At
2 or 24 h after re-exposure, the mice were once again
placed back in the training context for 5 min (test). In
the case of 0 min re-exposure, the mice remained in
their homecage (not re-exposed to the training cham-
ber), but were treated with the drugs. Memory was
assessed as the percentage of time spent freezing in the
training context. Freezing behavior (defined as complete
lack of movement, except for respiration) was measured
automatically as described previously (O’HARA & CO.,
LTD., Tokyo, Japan) [70]. Tiq-A or VEH was systemic-
ally injected (an i.p. injection) at 30 min before training
or re-exposure (see Figs. 4, 5, and 6).
Immunohistochemistry
IHC was performed as described previously [39, 41, 63,
65, 67]. After anesthetization, all mice were perfused
with 4 % paraformaldehyde. Brains were then removed,
fixed overnight, transferred to 30 % sucrose, and stored
at 4 °C. Coronal sections (30 μm) were cut in a cryostat.
The sections were pretreated with 4 % paraformalde-
hyde for 20 min and 3 % H2O2 in methanol for 1 h,
followed by incubation in a blocking solution (phos-
phate-buffered saline [PBS] plus 1 % goat serum albu-
min, 1 mg/mL bovine serum albumin, and 0.05 %
Triton X-100) for 3 h at 4 °C. Consecutive sections
were incubated with a polyclonal rabbit primary anti-
body for anti-c-fos (Ab-5; 1:5000; Millipore, MA,
USA) in the blocking solution over 2 nights at 4 °C.
Subsequently, the sections were washed with PBS and
incubated for 4 h at room temperature with biotinyl-
ated goat anti-rabbit IgG (SAB-PO Kit; Nichirei Bio-
sciences, Tokyo, Japan), followed by 1 h at room
temperature in streptavidin-biotin-peroxidase complex
(SAB-PO Kit). Immunoreactivity was detected with a
DAB substrate kit (Nichirei Biosciences). Structures
were defined anatomically according to the atlas of
Paxinos and Franklin [68]. Quantification of c-fos-
positive cells in sections (100 × 100 μm) of the mPFC
(bregma between +2.10 and +1.98 mm) and dorsal
hippocampus (bregma between −1.46 and −1.82 mm)
was performed using a computerized image analysis
system (WinROOF version 5.6 software; Mitani Cor-
poration, Fukui, Japan). Immunoreactive cells were
counted bilaterally with a fixed sample window across
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at least 3 sections by an experimenter blind to the
treatment condition. The expression levels of c-fos in
each group were expressed as the ratio of the aver-
aged values in the no-shock/VEH control group.
Open field test
An open field test was performed as described previ-
ously [71]. The mice received a micro-infusion of
3AB or VEH into the dorsal hippocampus or mPFC
at 5 min before the test (see Fig. 7a and b). Tiq-A or
VEH was systemically injected (an i.p. injection) at
30 min before the test (see Fig. 7c). The mice were
placed into the center of a square open field chamber
(50 × 50 × 40 cm) that was surrounded by white walls.
The total length of the path traveled (total distance) and
the time spent in the center square (30 × 30 cm; % center)
were measured over the course of 5 min using an auto-
matic monitoring system (O’HARA & CO., LTD.).
Data analysis
One-way or two-way factorial or repeated ANOVA
followed by post hoc Newman-Keuls comparison were
used to analyze the effects of drug, time, and condi-
tioning. A paired t-test was used to analyze the differ-
ences in freezing within each group between two
phases (first 5 min in 30 min re-exposure vs. test).
All values in the text and figure legends represent the
mean ± standard error of the mean (SEM).
Fig. 8 Cannula tip placements in the dorsal hippocampus and mPFC. Cannula tip placements from mice infused with each drug shown
in Fig. 1A (a), Fig. 1B (b), Fig. 1C (c), Fig. 1D (d), Fig. 1E (e), Fig. 2A (f), Fig. 2B (g), Fig. 2C (h), Fig. 2D (i), Fig. 2E (j), Fig. 2F (k), Fig. 3A
(l), Fig. 3B (m), Fig. 3C (n), Fig. 3D (o), Fig. 7A (p), and Fig. 7B (q). Schematic drawing of coronal sections from all micro-infused animals
(dorsal hippocampus, 1.94 mm posterior to the bregma; mPFC, 1.94 mm anterior to the bregma) [68]. Only mice with needle tips within
the boundaries of the dorsal hippocampus or mPFC were included in the data analysis
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